AGP Executive Report
Last update: 9 hours agoCancer Care & Research: Indian researchers unveiled “MutAIverse,” a generative AI platform that traces likely DNA damage drivers in head-and-neck cancer cases, including links to smokeless tobacco exposure, while the Science & Tech Ministry highlighted RK-251, an experimental “smart” cancer drug designed to activate mainly inside high-ROS tumour cells. Medicines & Enforcement: Delhi Crime Branch busted an interstate anti-cancer drug racket, arresting 17 and seizing medicines worth ~Rs 9 crore, alleging diversion from hospitals and sale of counterfeit/illicit drugs. Hospital & Patient Safety: Mumbai’s Mayor Ritu Tawde conducted a surprise inspection of a trauma care hospital, urging faster fixes to service gaps; separately, Mumbai neurosurgeons removed a large vascular brain tumour in about an hour with rapid recovery. Policy & Regulation: Supreme Court ruled police can’t investigate offences under the PCPNDT Act, and NMC proposed adding doctors’ active/inactive licence status and disciplinary details to the National Medical Register. Access & Public Health: Health Ministry expanded free TB screening to Islamic boarding schools; Delhi CM Rekha Gupta launched AI-focused skill and neighbourhood diagnostic centres in Moti Nagar. Business Moves: Redcliffe Labs appointed Ramesh Krishnan as an independent director to scale integrated diagnostics, and Mankind Pharma inked an in-licensing deal for insulin degludec products in India.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.